Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

BACKGROUND: Omadacycline is an aminomethylcycline antimicrobial approved by the US Food and Drug Administration in 2018 for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. It has in vitro activity against nontuberculous mycobacteria, including Mycobacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Jeffrey C, Dionne, Brandon, Richterman, Aaron, Vidal, Samuel J, Weiss, Zoe, Velásquez, Gustavo E, Marty, Francisco M, Sax, Paul E, Yawetz, Sigal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566545/
https://www.ncbi.nlm.nih.gov/pubmed/33094118
http://dx.doi.org/10.1093/ofid/ofaa415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566545/
https://www.ncbi.nlm.nih.gov/pubmed/33094118
http://dx.doi.org/10.1093/ofid/ofaa415

Ejemplares similares